This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and cardiovascular disorders. The compound is often employed in the production of β-lactamase inhibitors, which are critical in combating antibiotic-resistant bacterial infections. Additionally, its unique isoxazolidinone ring structure contributes to its role in creating molecules with enhanced bioavailability and stability, making it a crucial component in drug design and optimization processes.